Appier Recognized as an IDC Innovator for Asia-Pacific Data-as-a-Service Provider 2018
SINGAPORE – Media OutReach – March 27, 2018 – Appier, a leading artificial intelligence (AI) company, has been named by International Data Corporation (IDC)
PEAR Therapeutics to Collaborate with Novartis to Develop Prescription Digital Therapeutics
BOSTON, and SAN FRANCISCO, March 1, 2018—PEAR Therapeutics announced today that it has entered into a collaboration with Novartis to develop novel prescription digital
CAMBRIDGE, Mass., February 1, 2018 — Moderna Therapeutics, a clinical stage biotechnology company that is pioneering messenger RNA (mRNA) therapeutics and vaccines to create
Engine Biosciences Raises USD10 Million in Largest Institutional Seed Financing Seen in South East Asia
Singapore and San Francisco-based biotech company raises US$10 million in seed round from leading American and Asian investors; round was co-led by DHVC (Danhua
EDBI Participates in PEAR Therapeutics’ USD50 Million Series B Financing Round
BOSTON, and SAN FRANCISCO, January 2, 2018– PEAR Therapeutics, the leader in prescription digital therapeutics, today announced that it has successfully closed a $50
EDBI participates in Tessa Therapeutics’ USD 80 Million Financing Round
SINGAPORE – 20 December 2017 – Tessa Therapeutics, an international clinical stage biopharmaceutical company focusing on T cell therapy for solid tumors, today announced